LDX lumos diagnostics holdings limited

"In closing, CEO Doug Ward said: " The past few months have been...

  1. 1,449 Posts.
    lightbulb Created with Sketch. 61
    "In closing, CEO Doug Ward said: " The past few months have been critical for Lumos and for FebriDx®,
    marked by a series of very significant milestones that are not only advancing our U.S. regulatory pathway
    but also laying the foundation for FebriDx® as a true platform diagnostic. The distribution partnership with
    PHASE Scientific represents the culmination of years of hard work by our exceptional team. I remain deeply
    confident in the tangible benefits of FebriDx® and the meaningful impact it can have on patient care, clinical
    decision-making, and broader healthcare system efficiencies."

    "Our CLIA Waiver study for FebriDx® continues to progress well, with study completion expected around
    August 2025, with our FDA CLIA waiver application expected to be submitted within approximately one
    month of completion.
    Encouragingly, we’ve seen strong early support from U.S. public payors, which we
    believe will be the catalyst for broader adoption by private payors in due course."
    "I’m sincerely grateful for the continued backing of our two largest shareholders, Tenmile and Ryder Capital.
    The non-dilutive funding facility, along with contracted FebriDx® distribution fees and future milestone
    payments from our partners, positions Lumos well to meet working capital needs as we advance towards
    the anticipated granting of CLIA waiver."

    “Looking ahead, we remain firmly focused on our strategic priorities and committed to building a strong,
    sustainable business that delivers long-term value for patients, partners, and shareholders alike.”

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.2¢
Change
0.004(5.88%)
Mkt cap ! $53.89M
Open High Low Value Volume
7.1¢ 7.4¢ 6.9¢ $516.9K 7.209M

Buyers (Bids)

No. Vol. Price($)
2 301427 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 361833 3
View Market Depth
Last trade - 16.15pm 25/07/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.